Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Research Report 2023

Report ID: 1808034 | Published Date: Jan 2025 | No. of Page: 88 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Peripheral Parenteral Nutrition (PPN)
        1.2.3 Total Parenteral Nutrition (TPN)
    1.3 Market by Application
        1.3.1 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Home
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Perspective (2017-2028)
    2.2 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Growth Trends by Region
        2.2.1 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Historic Market Size by Region (2017-2022)
        2.2.3 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Forecasted Market Size by Region (2023-2028)
    2.3 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Dynamics
        2.3.1 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Industry Trends
        2.3.2 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Drivers
        2.3.3 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Challenges
        2.3.4 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Players by Revenue
        3.1.1 Global Top Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Players by Revenue (2017-2022)
        3.1.2 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue Market Share by Players (2017-2022)
    3.2 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue
    3.4 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Concentration Ratio
        3.4.1 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue in 2021
    3.5 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Key Players Head office and Area Served
    3.6 Key Players Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product Solution and Service
    3.7 Date of Enter into Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Breakdown Data by Type
    4.1 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Historic Market Size by Type (2017-2022)
    4.2 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Forecasted Market Size by Type (2023-2028)
5 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Breakdown Data by Application
    5.1 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Historic Market Size by Application (2017-2022)
    5.2 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size (2017-2028)
    6.2 North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2017-2022)
    6.3 North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size (2017-2028)
    7.2 Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2017-2022)
    7.3 Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size (2017-2028)
    8.2 Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2017-2022)
    8.3 Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size (2017-2028)
    9.2 Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2017-2022)
    9.3 Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size (2017-2028)
    10.2 Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2017-2022)
    10.3 Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Eurofarma
        11.1.1 Eurofarma Company Detail
        11.1.2 Eurofarma Business Overview
        11.1.3 Eurofarma Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
        11.1.4 Eurofarma Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
        11.1.5 Eurofarma Recent Development
    11.2 Corporacion De Laboratorios Farmaceuticos
        11.2.1 Corporacion De Laboratorios Farmaceuticos Company Detail
        11.2.2 Corporacion De Laboratorios Farmaceuticos Business Overview
        11.2.3 Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
        11.2.4 Corporacion De Laboratorios Farmaceuticos Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
        11.2.5 Corporacion De Laboratorios Farmaceuticos Recent Development
    11.3 Baxter International Inc.
        11.3.1 Baxter International Inc. Company Detail
        11.3.2 Baxter International Inc. Business Overview
        11.3.3 Baxter International Inc. Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
        11.3.4 Baxter International Inc. Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
        11.3.5 Baxter International Inc. Recent Development
    11.4 Kelun Pharma
        11.4.1 Kelun Pharma Company Detail
        11.4.2 Kelun Pharma Business Overview
        11.4.3 Kelun Pharma Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
        11.4.4 Kelun Pharma Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
        11.4.5 Kelun Pharma Recent Development
    11.5 B. Braun
        11.5.1 B. Braun Company Detail
        11.5.2 B. Braun Business Overview
        11.5.3 B. Braun Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
        11.5.4 B. Braun Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
        11.5.5 B. Braun Recent Development
    11.6 Fresenius
        11.6.1 Fresenius Company Detail
        11.6.2 Fresenius Business Overview
        11.6.3 Fresenius Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
        11.6.4 Fresenius Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
        11.6.5 Fresenius Recent Development
    11.7 Teva Pharmaceutical Industries
        11.7.1 Teva Pharmaceutical Industries Company Detail
        11.7.2 Teva Pharmaceutical Industries Business Overview
        11.7.3 Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
        11.7.4 Teva Pharmaceutical Industries Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
        11.7.5 Teva Pharmaceutical Industries Recent Development
    11.8 Pfizer (Hospira)
        11.8.1 Pfizer (Hospira) Company Detail
        11.8.2 Pfizer (Hospira) Business Overview
        11.8.3 Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
        11.8.4 Pfizer (Hospira) Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
        11.8.5 Pfizer (Hospira) Recent Development
    11.9 Ostuka Pharmaceutical
        11.9.1 Ostuka Pharmaceutical Company Detail
        11.9.2 Ostuka Pharmaceutical Business Overview
        11.9.3 Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
        11.9.4 Ostuka Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
        11.9.5 Ostuka Pharmaceutical Recent Development
    11.10 Laboratorios Biogalenic
        11.10.1 Laboratorios Biogalenic Company Detail
        11.10.2 Laboratorios Biogalenic Business Overview
        11.10.3 Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
        11.10.4 Laboratorios Biogalenic Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
        11.10.5 Laboratorios Biogalenic Recent Development
    11.11 Laboratorios Finlay
        11.11.1 Laboratorios Finlay Company Detail
        11.11.2 Laboratorios Finlay Business Overview
        11.11.3 Laboratorios Finlay Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
        11.11.4 Laboratorios Finlay Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
        11.11.5 Laboratorios Finlay Recent Development
    11.12 Grifols International
        11.12.1 Grifols International Company Detail
        11.12.2 Grifols International Business Overview
        11.12.3 Grifols International Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
        11.12.4 Grifols International Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
        11.12.5 Grifols International Recent Development
    11.13 Fresenius Kabi
        11.13.1 Fresenius Kabi Company Detail
        11.13.2 Fresenius Kabi Business Overview
        11.13.3 Fresenius Kabi Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
        11.13.4 Fresenius Kabi Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
        11.13.5 Fresenius Kabi Recent Development
    11.14 Sichuan Kelun Pharmaceutical
        11.14.1 Sichuan Kelun Pharmaceutical Company Detail
        11.14.2 Sichuan Kelun Pharmaceutical Business Overview
        11.14.3 Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
        11.14.4 Sichuan Kelun Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
        11.14.5 Sichuan Kelun Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Peripheral Parenteral Nutrition (PPN)
    Table 3. Key Players of Total Parenteral Nutrition (TPN)
    Table 4. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Region (2017-2022)
    Table 8. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Region (2023-2028)
    Table 10. Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Trends
    Table 11. Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Drivers
    Table 12. Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Challenges
    Table 13. Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Restraints
    Table 14. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Players (2017-2022)
    Table 16. Global Top Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) as of 2021)
    Table 17. Ranking of Global Top Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product Solution and Service
    Table 21. Date of Enter into Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue Market Share by Type (2017-2022)
    Table 25. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue Market Share by Type (2023-2028)
    Table 27. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue Market Share by Application (2017-2022)
    Table 29. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue Market Share by Application (2023-2028)
    Table 31. North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Eurofarma Company Detail
    Table 42. Eurofarma Business Overview
    Table 43. Eurofarma Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product
    Table 44. Eurofarma Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022) & (US$ Million)
    Table 45. Eurofarma Recent Development
    Table 46. Corporacion De Laboratorios Farmaceuticos Company Detail
    Table 47. Corporacion De Laboratorios Farmaceuticos Business Overview
    Table 48. Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product
    Table 49. Corporacion De Laboratorios Farmaceuticos Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022) & (US$ Million)
    Table 50. Corporacion De Laboratorios Farmaceuticos Recent Development
    Table 51. Baxter International Inc. Company Detail
    Table 52. Baxter International Inc. Business Overview
    Table 53. Baxter International Inc. Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product
    Table 54. Baxter International Inc. Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022) & (US$ Million)
    Table 55. Baxter International Inc. Recent Development
    Table 56. Kelun Pharma Company Detail
    Table 57. Kelun Pharma Business Overview
    Table 58. Kelun Pharma Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product
    Table 59. Kelun Pharma Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022) & (US$ Million)
    Table 60. Kelun Pharma Recent Development
    Table 61. B. Braun Company Detail
    Table 62. B. Braun Business Overview
    Table 63. B. Braun Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product
    Table 64. B. Braun Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022) & (US$ Million)
    Table 65. B. Braun Recent Development
    Table 66. Fresenius Company Detail
    Table 67. Fresenius Business Overview
    Table 68. Fresenius Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product
    Table 69. Fresenius Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022) & (US$ Million)
    Table 70. Fresenius Recent Development
    Table 71. Teva Pharmaceutical Industries Company Detail
    Table 72. Teva Pharmaceutical Industries Business Overview
    Table 73. Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product
    Table 74. Teva Pharmaceutical Industries Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022) & (US$ Million)
    Table 75. Teva Pharmaceutical Industries Recent Development
    Table 76. Pfizer (Hospira) Company Detail
    Table 77. Pfizer (Hospira) Business Overview
    Table 78. Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product
    Table 79. Pfizer (Hospira) Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022) & (US$ Million)
    Table 80. Pfizer (Hospira) Recent Development
    Table 81. Ostuka Pharmaceutical Company Detail
    Table 82. Ostuka Pharmaceutical Business Overview
    Table 83. Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product
    Table 84. Ostuka Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022) & (US$ Million)
    Table 85. Ostuka Pharmaceutical Recent Development
    Table 86. Laboratorios Biogalenic Company Detail
    Table 87. Laboratorios Biogalenic Business Overview
    Table 88. Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product
    Table 89. Laboratorios Biogalenic Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022) & (US$ Million)
    Table 90. Laboratorios Biogalenic Recent Development
    Table 91. Laboratorios Finlay Company Detail
    Table 92. Laboratorios Finlay Business Overview
    Table 93. Laboratorios Finlay Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN)Product
    Table 94. Laboratorios Finlay Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022) & (US$ Million)
    Table 95. Laboratorios Finlay Recent Development
    Table 96. Grifols International Company Detail
    Table 97. Grifols International Business Overview
    Table 98. Grifols International Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN)Product
    Table 99. Grifols International Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022) & (US$ Million)
    Table 100. Grifols International Recent Development
    Table 101. Fresenius Kabi Company Detail
    Table 102. Fresenius Kabi Business Overview
    Table 103. Fresenius Kabi Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN)Product
    Table 104. Fresenius Kabi Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022) & (US$ Million)
    Table 105. Fresenius Kabi Recent Development
    Table 106. Sichuan Kelun Pharmaceutical Company Detail
    Table 107. Sichuan Kelun Pharmaceutical Business Overview
    Table 108. Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN)Product
    Table 109. Sichuan Kelun Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022) & (US$ Million)
    Table 110. Sichuan Kelun Pharmaceutical Recent Development
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Type: 2021 VS 2028
    Figure 2. Peripheral Parenteral Nutrition (PPN) Features
    Figure 3. Total Parenteral Nutrition (TPN) Features
    Figure 4. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Application in 2021 & 2028
    Figure 5. Hospital Case Studies
    Figure 6. Home Case Studies
    Figure 7. Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Report Years Considered
    Figure 8. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 9. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Region: 2021 VS 2028
    Figure 11. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Players in 2021
    Figure 12. Global Top Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) as of 2021)
    Figure 13. The Top 10 and 5 Players Market Share by Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue in 2021
    Figure 14. North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 15. North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Country (2017-2028)
    Figure 16. United States Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. Canada Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Country (2017-2028)
    Figure 20. Germany Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. France Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. U.K. Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Italy Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Russia Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Nordic Countries Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Region (2017-2028)
    Figure 28. China Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Japan Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. South Korea Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Southeast Asia Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. India Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Australia Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Country (2017-2028)
    Figure 36. Mexico Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Brazil Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Country (2017-2028)
    Figure 40. Turkey Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Saudi Arabia Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Eurofarma Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
    Figure 43. Corporacion De Laboratorios Farmaceuticos Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
    Figure 44. Baxter International Inc. Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
    Figure 45. Kelun Pharma Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
    Figure 46. B. Braun Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
    Figure 47. Fresenius Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
    Figure 48. Teva Pharmaceutical Industries Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
    Figure 49. Pfizer (Hospira) Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
    Figure 50. Ostuka Pharmaceutical Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
    Figure 51. Laboratorios Biogalenic Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
    Figure 52. Laboratorios Finlay Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
    Figure 53. Grifols International Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
    Figure 54. Fresenius Kabi Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
    Figure 55. Sichuan Kelun Pharmaceutical Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Eurofarma
Corporacion De Laboratorios Farmaceuticos
Baxter International Inc.
Kelun Pharma
B. Braun
Fresenius
Teva Pharmaceutical Industries
Pfizer (Hospira)
Ostuka Pharmaceutical
Laboratorios Biogalenic
Laboratorios Finlay
Grifols International
Fresenius Kabi
Sichuan Kelun Pharmaceutical
Frequently Asked Questions
Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Dialysis Cartridge

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More